Laetitia is an investor at SR One, based in London. She brings strong experience in early and late-phase clinical programs, designing and executing clinical development strategies with a therapeutic expertise in Gene therapy, Neuroscience and Rare Diseases. Prior to joining SR One, she worked in clinical development at Orchard Therapeutics where she played a key role in the delivery of a gene therapy (Libmeldy) for Marketing Authorization.  

Laetitia received her B.Sc in Medical Sciences from the University of Edinburgh, her MPhil in Translational Medicine, her Ph.D in Clinical Neuroscience from the University of Cambridge and MBA from INSEAD.